SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Gustafsson O) srt2:(1995-1999)"

Sökning: WFRF:(Gustafsson O) > (1995-1999)

  • Resultat 11-20 av 93
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  •  
17.
  •  
18.
  • Nilsson, K O, et al. (författare)
  • Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
  • 1996
  • Ingår i: Journal of Clinical Endocrinology and Metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 81, s. 635-
  • Tidskriftsartikel (refereegranskat)abstract
    • The spontaneous growth process in Turner's syndrome is characterized by a progressive decline in height velocity during childhood and no pubertal growth spurt. Therefore, therapy aimed at improving height during childhood as well as increasing final height is desirable for most girls with Turner's syndrome. Forty-five girls with Turner's syndrome, 9-16 yr of age (mean age, 12.2 yr), were allocated to three study groups. Group 1 (n = 13) was initially treated with oxandrolone alone; after 1 yr of treatment, GH without (group 1a; n = 6) or with (group 1b; n = 7) ethinyl estradiol was added. Group 2 (n = 17) was treated with GH plus oxandrolone. Group 3 (n = 15) was treated with GH, oxandrolone, and ethinyl estradiol. The dosage were: GH, 0.1 IU/kg.day; oxandrolone, 0.05 mg/kg.day; and ethinyl estradiol, 100 ng/kg.day. A height of 150 cm or more was achieved in 61%, 75%, and 60% of the girls in groups 1, 2, and 3, respectively. The most impressive increase in height was seen in group 2. In this group the mean final height was 154.2 cm (SD = 6.6), which is equivalent to a mean net gain of 8.5 cm (SD = 4.6) over the projected final height. In group 3, in which ethinyl estradiol was included from the start of therapy, the initially good height velocity decelerated after 1-2 yr of treatment. Their mean final height was 151.1 (SD = 4.6) cm, equivalent to a mean net gain of 3.0 cm (SD = 3.8). A similar growth-decelerating effect of ethinyl estradiol was seen in group 1b. We conclude that in girls with Turner's syndrome who are older than 9 yr of age, treatment with GH in combination with oxandrolone results in significant growth acceleration, imitating that in normal puberty, leading to a more favorable height during childhood. This mode of treatment also results in a significantly increased final height, permitting a great number of the girls to attain a final height of more than 150 cm. However, early addition of estrogen decelerates the height velocity and reduces the gain in height.
  •  
19.
  •  
20.
  • Akner, Gunnar, 1953-, et al. (författare)
  • Glucocorticoid receptor inhibits microtubule assembly in vitro.
  • 1995
  • Ingår i: Molecular and cellular endocrinology. - : Elsevier BV. - 0303-7207 .- 1872-8057. ; 110:1-2, s. 49-54
  • Tidskriftsartikel (refereegranskat)abstract
    • The effect of glucocorticoid hormones, purified glucocorticoid receptor (GR) and purified heat shock protein M(r) 90,000 (hsp90) on microtubule (MT) assembly in vitro was tested by a spectrophotometric MT assembly assay and electron microscopy. GR significantly prolonged the nucleation phase, slowed down the assembly rate and reduced the maximal amplitude of MT assembly compared with control. The effects were partially reversed by the addition of glucocorticoid hormone. GR associated with MTs. These results indicate that GR affects MT assembly in vitro, which may be a functional correlate to the structural association of GR with MTs. This implies that factors affecting GR may affect MT assembly in vivo.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 93
Typ av publikation
tidskriftsartikel (82)
konferensbidrag (7)
bokkapitel (2)
rapport (1)
recension (1)
Typ av innehåll
refereegranskat (82)
övrigt vetenskapligt/konstnärligt (10)
populärvet., debatt m.m. (1)
Författare/redaktör
Gustafsson, J (19)
Gustafsson, JA (12)
Gustafsson, LL (10)
ERICSSON, O (10)
Kampe, O (9)
Gustafsson, A (8)
visa fler...
Norming, U (7)
Rorsman, F (7)
Tuvemo, T (6)
Albertsson Wikland, ... (6)
Moell, C (6)
Ritzén, M (6)
CARLSSON, A (5)
Ringden, O (5)
Nyman, CR (5)
Hagenas, L (5)
Marcus, C (5)
Svensson, E. (5)
Aronsson, S (5)
Rombo, L (4)
Alm, J (4)
Svensson, O (4)
Ahlberg, G (4)
Nilsson, KO (4)
Gustafsson, L (3)
Inganäs, Olle (3)
Nilsson, O (3)
Berggren, Magnus (3)
Gustafsson, Göran (3)
Ryden, S (3)
Petrescu, A (3)
Johansson, C. (3)
Wallentin, L (3)
IVARSSON, SA (3)
Walter, H (3)
Swahn, E (3)
Andersson, Mats R (3)
Gustafsson, C (3)
Holmberg, B (3)
Schulman, S (3)
Bergqvist, M. (3)
Malmqvist, K (3)
Perk, J. (3)
Lindmarker, P (3)
MODE, A (3)
Winiarski, J (3)
Larfars, G (3)
Dalianis, T (3)
Hedman, A (3)
Kriström, Berit (3)
visa färre...
Lärosäte
Karolinska Institutet (65)
Uppsala universitet (28)
Linköpings universitet (5)
Umeå universitet (4)
Karlstads universitet (3)
Lunds universitet (2)
visa fler...
Göteborgs universitet (1)
Kungliga Tekniska Högskolan (1)
Luleå tekniska universitet (1)
Högskolan i Gävle (1)
Örebro universitet (1)
Högskolan i Skövde (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (91)
Svenska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (5)
Teknik (3)
Naturvetenskap (2)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy